{"entity":{"type":"insider","cik":"0001380901","url":"/insider/0001380901","json_url":"/insider/0001380901.json","name":"Chang Michael N","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":9,"first":"2007-02-14","last":"2009-12-29","span_basis":"filed_date"},"name_variants":[{"name":"Chang Michael N","source":"filing","n_filings":9,"first_seen":"2007-02-14","last_seen":"2009-12-29"}],"transactions":[{"id":5786566,"accession":"0001142576-09-000035","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001142576-09-000035","line_url":"/filing/0001142576-09-000035#line-2","is_derivative":false,"issuer_cik":"0001142576","issuer_name":"OPTIMER PHARMACEUTICALS INC","issuer_ticker":"OPTR","issuer_name_source":null,"issuer_url":"/issuer/0001142576","owner_cik":"0001380901","owner_name":"Chang Michael N","owner_display_name":"Chang Michael N","owner_url":"/insider/0001380901","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":10.8,"price_display":"10.80","price_state":"stated","total_value":86400.0,"total_display":"86,400.00","total_whole":"86,400","shares_owned_after":220396.0,"shares_owned_after_display":"220,396","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-29","filed_date":"2009-12-29","scope":"insider"},{"id":5786564,"accession":"0001142576-09-000035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001142576-09-000035","line_url":"/filing/0001142576-09-000035#line-1","is_derivative":false,"issuer_cik":"0001142576","issuer_name":"OPTIMER PHARMACEUTICALS INC","issuer_ticker":"OPTR","issuer_name_source":null,"issuer_url":"/issuer/0001142576","owner_cik":"0001380901","owner_name":"Chang Michael N","owner_display_name":"Chang Michael N","owner_url":"/insider/0001380901","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":10.85,"price_display":"10.85","price_state":"stated","total_value":108500.0,"total_display":"108,500.00","total_whole":"108,500","shares_owned_after":212396.0,"shares_owned_after_display":"212,396","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-28","filed_date":"2009-12-29","scope":"insider"},{"id":5637069,"accession":"0001142576-09-000030","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001142576-09-000030","line_url":"/filing/0001142576-09-000030","is_derivative":false,"issuer_cik":"0001142576","issuer_name":"OPTIMER PHARMACEUTICALS INC","issuer_ticker":"OPTR","issuer_name_source":null,"issuer_url":"/issuer/0001142576","owner_cik":"0001380901","owner_name":"Chang Michael N","owner_display_name":"Chang Michael N","owner_url":"/insider/0001380901","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":11.516,"price_display":"11.52","price_state":"stated","total_value":172740.0,"total_display":"172,740.00","total_whole":"172,740","shares_owned_after":195396.0,"shares_owned_after_display":"195,396","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-25","filed_date":"2009-11-25","scope":"insider","n_lines":2},{"id":3464624,"accession":"0001380901-08-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001380901-08-000001","line_url":"/filing/0001380901-08-000001#line-1","is_derivative":false,"issuer_cik":"0001142576","issuer_name":"OPTIMER PHARMACEUTICALS INC","issuer_ticker":"OPTR","issuer_name_source":null,"issuer_url":"/issuer/0001142576","owner_cik":"0001380901","owner_name":"Chang Michael N","owner_display_name":"Chang Michael N","owner_url":"/insider/0001380901","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":35000.0,"total_display":"35,000.00","total_whole":"35,000","shares_owned_after":173580.0,"shares_owned_after_display":"173,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-13","filed_date":"2008-06-17","scope":"insider"},{"id":3354823,"accession":"0001142576-08-000012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001142576-08-000012","line_url":"/filing/0001142576-08-000012","is_derivative":false,"issuer_cik":"0001142576","issuer_name":"OPTIMER PHARMACEUTICALS INC","issuer_ticker":"OPTR","issuer_name_source":null,"issuer_url":"/issuer/0001142576","owner_cik":"0001380901","owner_name":"Chang Michael N","owner_display_name":"Chang Michael N","owner_url":"/insider/0001380901","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4542.0,"shares_display":"4,542","price_per_share":6.035,"price_display":"6.04","price_state":"stated","total_value":27410.97,"total_display":"27,410.97","total_whole":"27,411","shares_owned_after":168580.0,"shares_owned_after_display":"168,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-15","filed_date":"2008-05-16","scope":"insider","n_lines":2},{"id":7767260,"accession":"0001142576-07-000017","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001142576-07-000017","line_url":"/filing/0001142576-07-000017","is_derivative":false,"issuer_cik":"0001142576","issuer_name":"OPTIMER PHARMACEUTICALS INC","issuer_ticker":"OPTR","issuer_name_source":null,"issuer_url":"/issuer/0001142576","owner_cik":"0001380901","owner_name":"Chang Michael N","owner_display_name":"Chang Michael N","owner_url":"/insider/0001380901","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":5.95,"price_display":"5.95","price_state":"stated","total_value":11900.0,"total_display":"11,900.00","total_whole":"11,900","shares_owned_after":245423.0,"shares_owned_after_display":"245,423","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-11-15","filed_date":"2007-11-19","scope":"insider","n_lines":2},{"id":7237358,"accession":"0001142576-07-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001142576-07-000003","line_url":"/filing/0001142576-07-000003#line-1","is_derivative":false,"issuer_cik":"0001142576","issuer_name":"OPTIMER PHARMACEUTICALS INC","issuer_ticker":"OPTR","issuer_name_source":null,"issuer_url":"/issuer/0001142576","owner_cik":"0001380901","owner_name":"Chang Michael N","owner_display_name":"Chang Michael N","owner_url":"/insider/0001380901","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":8.2,"price_display":"8.20","price_state":"stated","total_value":246000.0,"total_display":"246,000.00","total_whole":"246,000","shares_owned_after":169580.0,"shares_owned_after_display":"169,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-09","filed_date":"2007-08-10","scope":"insider"},{"id":7864971,"accession":"0001142576-07-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001142576-07-000001","line_url":"/filing/0001142576-07-000001#line-1","is_derivative":false,"issuer_cik":"0001142576","issuer_name":"OPTIMER PHARMACEUTICALS INC","issuer_ticker":"OPTR","issuer_name_source":null,"issuer_url":"/issuer/0001142576","owner_cik":"0001380901","owner_name":"Chang Michael N","owner_display_name":"Chang Michael N","owner_url":"/insider/0001380901","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":9.05,"price_display":"9.05","price_state":"stated","total_value":90500.0,"total_display":"90,500.00","total_whole":"90,500","shares_owned_after":139580.0,"shares_owned_after_display":"139,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-06","filed_date":"2007-08-08","scope":"insider"},{"id":7717370,"accession":"0001380901-07-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001380901-07-000002","line_url":"/filing/0001380901-07-000002","is_derivative":false,"issuer_cik":"0001142576","issuer_name":"OPTIMER PHARMACEUTICALS INC","issuer_ticker":"OPTR","issuer_name_source":null,"issuer_url":"/issuer/0001142576","owner_cik":"0001380901","owner_name":"Chang Michael N","owner_display_name":"Chang Michael N","owner_url":"/insider/0001380901","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":9.86,"price_display":"9.86","price_state":"stated","total_value":98600.0,"total_display":"98,600.00","total_whole":"98,600","shares_owned_after":124580.0,"shares_owned_after_display":"124,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-07-16","filed_date":"2007-07-18","scope":"insider","n_lines":2},{"id":7347046,"accession":"0001104659-07-011405","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-07-011405","line_url":"/filing/0001104659-07-011405#line-4","is_derivative":false,"issuer_cik":"0001142576","issuer_name":"OPTIMER PHARMACEUTICALS INC","issuer_ticker":"OPTR","issuer_name_source":null,"issuer_url":"/issuer/0001142576","owner_cik":"0001380901","owner_name":"Chang Michael N","owner_display_name":"Chang Michael N","owner_url":"/insider/0001380901","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":114965.0,"shares_display":"114,965","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":804755.0,"total_display":"804,755.00","total_whole":"804,755","shares_owned_after":119580.0,"shares_owned_after_display":"119,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-14","filed_date":"2007-02-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":14,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001142576","name":"OPTIMER PHARMACEUTICALS INC","url":"/issuer/0001142576","role":"Director, Officer (CEO and President)","n_filings":9,"first_seen":"2007-02-14","last_seen":"2009-12-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001380901","retrieved_at":"2026-08-24T14:10:22+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}